Navigation Links
US Peptides Updates Website with New Information

TAMPA, Fla., Nov. 12, 2013 /PRNewswire-iReach/ -- US Peptides, a leading supplier of research peptides in the United States has changed the layout of the site and improved content for better user experience at


The redesigned website features an easy to use menu to quickly and efficiently locate product as well as user friendly articles which are based on past studies and research regarding the very same research peptides available on the web site.

As an example of content the article titled "What IGF-1 Does in the Body" (located here  ) goes on to explain what the IGF-1 peptide does from ingestion on. For those that do not recall, there was a former Super Bowl winning middle linebacker that had some rumors surrounding him based on some accusations that he may have used this type of product to improve healing and/or increase performance on the field.

US Peptides views this web site as a step towards developing an impressive online presence and they plan on continuing to build upon this solid foundation in the future.

In an effort to celebrate the new redesign and focus on a fast, efficient, quality site US Peptides is giving a 10% discount on all orders with 10 items or more in the shopping cart. There is no need to add a coupon or special code, this discount is applied automatically at checkout.

About US Peptides, LLC

US Peptides, LLC founded in 2010 to work with researchers doing studies and clinical trials with peptides. In addition to CJC-1295 research peptide, US Peptides also provides researchers with other much in demand peptides including GHRP, Melanotan, Semorelin, IGF-LR3, Growth Factor, GHRP 2, Hexarelin, MGF, MGF Ipamorelin, Mechano Growth Factor, and IGF. Disclaimer: All products listed and provided through are intended for research purposes only. We do not promote the personal use of these products. Products provided by are not intended for use in food products or as any type of drug. Our products are not intended to treat, prevent, mitigate or cure any disease or medical condition and are for research purposes only.

Media Contact: Don Pierce, US Peptides LLC, 727-210-7821,

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. US Peptides Discusses HGH and Growth Hormone Releasing Peptides and How They Affect Performance
2. Arg-Phe-amide-related peptides influence gonadotropin-releasing hormone neurons
3. Updates in Interventional Radiology accents emerging trends, practice growth
4. NREL updates solar radiation database
5. Biometrics Market Research Updates From Global Information
6. Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line
7. Accelrys Hosts Analyst Day, Updates Calendar Year 2013 Outlook
8. NIST launches new website to educate industry about alternatives to mercury thermometers
9. Revealing climate change website wins global award
10. Website for new open-access journal, eLife, introduced today
11. The Website You Have to Log Into
Post Your Comments:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology: